Warning letter
InvaDerm, Inc.: warning letter of Jun 3, 2026
FDA warning letter 713177 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 713177 |
|---|---|
| Company | InvaDerm, Inc. |
| Subject | Electronic Drug Registration and Listing System (eDRLS)/Violations |
| Issue date | Jun 3, 2026 |
| Posted date | Jun 16, 2026 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 201.128 |
| Inspection city | Somerset |
| Inspection ZIP | 08873-1344 |
| Inspection start date | Oct 15, 2024 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: